Publications by authors named "Francesca Bonello"

Claim this Profile
B
Better together: epcoritamab boosts R2 in FL.
Umberto Vitolo, Francesca Bonello

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL).
Mattia Novo, Pio Manlio Mirko Frascione, Alessia Castellino, Luigi Marcheselli, Samantha Deianira Dattoli, Francesca Bonello

Br J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of epcoritamab as a treatment for relapsed or refractory follicular lymphoma.
Francesca Bonello, Pio Manlio Mirko Frascione, Danilo Faraci, Umberto Vitolo

Expert Rev Anticancer Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter study on hematopoietic stemcell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents.
Roberto Mina, Maria Teresa Petrucci, Francesca Bonello, Velia Bongarzoni, Riccardo Saccardi

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia.
Giorgia Battipaglia, Annamaria Vincenzi, Giulia Falconi, Alessia Fiore, Francesco D'Agostino, Francesca Bonello

Curr Res Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
Mattia D'Agostino, David A Cairns, Juan José Lahuerta, Ruth Wester, Uta Bertsch, Francesca Bonello

J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting.
Francesca Bonello, Lorenzo Cani, Mattia D'Agostino

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma.
Francesca Bonello, Serena Rocchi, Gregorio Barilà, Michela Sandrone, Marco Talarico

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
Roberto Mina, Antonietta Pia Falcone, Sara Bringhen, Anna Marina Liberati, Norbert Pescosta, Francesca Bonello

Blood Cancer J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time?
Roberto Mina, Francesca Bonello, Stefania Oliva

Cancer J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?
Dario Ferrero, Francesca Bonello, Stefania Oliva, Francesca Gay, Mario Boccadoro

Leuk Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma.
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D'Agostino, Massimo Offidani

Blood· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies.
Roberto Mina, Francesca Bonello, Maria Teresa Petrucci, Anna Marina Liberati, Concetta Conticello

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score.
Mattia D'Agostino, Alessandra Larocca, Massimo Offidani, Anna Marina Liberati, Gianluca Gaidano, Francesca Bonello

Blood Cancer J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report.
Roberto Mina, Francesca Bonello, Francesca Gay, Elena Zamagni, Mario Boccadoro

Clin Lymphoma Myeloma Leuk· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma.
Francesca Bonello, Mariella Grasso, Mattia D'Agostino, Ivana Celeghini, Alessia Castellino

Pharmaceuticals (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients.
Francesca Bonello, Mario Boccadoro, Alessandra Larocca

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New drugs in early development for treating multiple myeloma: all that glitters is not gold.
Luca Bertamini, Francesca Bonello, Mario Boccadoro, Sara Bringhen

Expert Opin Investig Drugs· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving Toward Continuous Therapy in Multiple Myeloma.
Francesca Bonello, Giusy Cetani, Luca Bertamini, Francesca Gay, Alessandra Larocca

Clin Hematol Int· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma.
Francesca Bonello, Roberto Mina, Mario Boccadoro, Francesca Gay

Cancers (Basel)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis.
Francesca Bonello, Stefano Pulini, Stelvio Ballanti, Massimo Gentile, Stefano Spada

Cancers (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38 as an immunotherapeutic target in multiple myeloma.
Francesca Bonello, Mattia D'Agostino, Maria Moscvin, Chiara Cerrato, Mario Boccadoro

Expert Opin Biol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining treatment intensity in elderly patients with multiple myeloma.
Marco Salvini, Mattia D'Agostino, Francesca Bonello, Mario Boccadoro, Sara Bringhen

Expert Rev Anticancer Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How is patient care for multiple myeloma advancing?
Sonja Genadieva Stavric, Francesca Bonello, Sara Bringhen, Mario Boccadoro, Alessandra Larocca

Expert Rev Hematol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma.
Marco Salvini, Francesca Bonello, Mario Boccadoro, Alessandra Larocca

Expert Rev Anticancer Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis